Iothalamate and Urinary Clearance of Iohexol

Overview

About this study

The purose of this study is to validate the urinary clearance of iohexol as an alternative for urinary clearance for mGRF testing.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patient age ≥ 18 years.
Patient has presented to the Renal Studies Unit for a short renal clearance (iothalamate) study ordered by his/her health care provider.

Exclusion Criteria:

History of severe reaction to contrast agents or iodine.
Patients who are know to be pregnant.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 7/20/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Timothy Larson, M.D.	Closed for enrollment	Contact information: Timothy Larson M.D. (507) 284-3017 larson.timothy@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Timothy Larson, M.D.

Closed for enrollment

Contact information:

Timothy Larson M.D.

(507) 284-3017

larson.timothy@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials